Lowering levels of 'bad' cholesterol is a well-established approach to reduce the risk of cardiovascular disease (CVD), but a significant need remains for drugs that could help achieve this goal.

引言前蛋白转化酶枯草溶菌素9(Proprotein Convertase Subtilisin/ Kexin Type 9, PCSK9)是调控低密度脂蛋白胆固醇(Low-Density Lipoprotein Cholesterol, ...

Since the first description in 1872 (ref. 1) of Huntington's disease—a hereditary neurodegenerative disease characterized by progressive movement disorder, cognitive decline and psychiatric ...

A doctor has dispelled some prevalent myths surrounding cholesterol, highlighting the importance of carrying out regular ...

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

Dr Gubala also clarified some misunderstandings about the nature of cholesterol, noting that not all cholesterol is harmful and that health concerns arise from an imbalance rather than the ...

High levels of variability in cholesterol over time were linked to a significantly higher risk for dementia and cognitive ...

can help lower cholesterol and blood pressure. However, the authors advised caution due to the short-term nature of the clinical trials included, suggesting that more extended trials are necessary ...